Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis.
about
Antithrombotic Treatment for Recurrent Miscarriage: Bayesian Network Meta-Analysis and Systematic ReviewCurrent treatment of antiphospholipid syndrome: lights and shadows.EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndromeEvidence-based management of recurrent miscarriagesThe role of aspirin in women's healthAnti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss.Activation of ERK and NF-κB during HARE-Mediated Heparin Uptake Require Only One of the Four Endocytic Motifs.Pregnancy and autoimmune connective tissue diseasesLow dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage.Recurrent miscarriage and autoimmunity.Pregnancy outcomes in Japanese patients with SLE: retrospective review of 55 pregnancies at a university hospital.Can Factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcomes?: Results from a targeted evidence-based review.Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome.Inherited and acquired thrombophilias.Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome.LMWH to prevent placenta-mediated pregnancy complications: an update.Incidence, pathophysiology, and clinical manifestations of antiphospholipid syndrome.Current status and future prospects for the treatment of antiphospholipid syndrome.Behcet's disease and pregnancy-a case report and literature review.The challenge of pregnancy for patients with SLE.Impact of anticardiolipin antibody on the outcome of in vitro fertilization and embryo transfer.Challenges of Anticoagulation Therapy in Pregnancy.Low-dose aspirin plus low-molecular-weight heparin for the prevention of pre-eclampsia: yes, no or maybe.Low-molecular-weight-heparin and pregnancy, when the dose does it: a nephrologist's opinion: a rebuttal.Therapy for antiphospholipid miscarriages: Throwing the baby out with the bathwater?Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials.Diagnosis and management of the antiphospholipid syndrome.Paternal HLA-C is a risk factor in unexplained recurrent miscarriage.Clinical feature and anti-phospholipid antibody profiles of pregnancy failure in young women with antiphospholipid antibody syndrome treated with conventional therapy.Antiphospholipid antibodies affect human endometrial angiogenesis: protective effect of a synthetic peptide (TIFI) mimicking the phospholipid binding site of β(2) glycoprotein I.Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/050).High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome
P2860
Q26777548-C94F65EB-BB1D-4B04-8290-B27D98DFB903Q33423959-6D9E8D56-BAB9-4581-9C2C-4AAE191F47A4Q33731711-180914DE-646B-4657-944D-1A3FF71762D3Q34500272-8F3A300A-0BB6-4E76-9A5C-5436A00C9E11Q35119642-E4C330E1-129E-4A68-9CAC-1CC1D52FDE10Q35854768-7B22E947-B06E-411E-8080-7674FA1046DDQ35995906-9A4DB1B6-4A79-4033-86E8-BE649520E542Q37100267-126F6917-FC19-42BA-8D0C-059A99D8CB78Q37479967-A124D2CB-B028-40AE-9AD2-BB93652F4639Q37821493-8709D024-4D97-4FE2-8227-0AA01F7654FEQ37851849-330F0389-F8D7-4D38-9669-1B9D6A93419FQ37975108-1BF98F35-D5F5-4522-82F5-4F3F874BC0E5Q38092150-D2FF4DF7-B77C-407F-96E0-394E55843AD3Q38125276-01801381-D96E-4F78-9A8D-0633043DE867Q38258585-5BF76BC9-BCF2-4204-B054-F14022583CC2Q38268419-7E5D5662-EA59-4E79-9524-B60980B35B05Q38591312-C71DE34D-3782-4E0F-8FC3-0AD222DD0F30Q38818425-98A7A4B0-D55B-40C2-AE8A-8440A993FD0CQ38863904-7122FAE8-4DCB-44F8-951F-5261AA9B6081Q43490656-D38C3193-4358-4711-8A83-611D3FD7DB9BQ43958996-C5EAD9F5-AF88-48E4-BB9E-B2D1F2C38D0BQ47252275-266EADF7-4E93-48B3-827B-0F1879F986AFQ47306143-02C315C3-D0C8-4254-BAFD-A6F9F9EF288EQ47367501-49F2BABE-E9E2-4531-9DA4-5AEB04E8BB1BQ47386457-0CD1A393-BD9E-4B59-9990-80B5F9464B6EQ47407572-6BD4A992-DFD7-4BF8-B48B-D28FFFCF319DQ47982275-99EF9B92-8EB1-43F5-A575-D29A0FD25A58Q48178955-1AB7B05C-88F6-4413-B39F-E26E14C764A9Q50079687-01D90BBB-C11C-4311-AEC3-DD2FD97A5AD6Q51014103-D1C9C832-0E6D-47DE-A612-DF1A1CAD1E43Q54957684-6EB56858-43D4-4391-8B43-8A702FCBCC4BQ58869486-A6527E46-6A53-479E-8431-247C7EDB3BA6
P2860
Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Heparin treatment in antiphosp ...... atic review and meta-analysis.
@en
Heparin treatment in antiphosp ...... atic review and meta-analysis.
@nl
type
label
Heparin treatment in antiphosp ...... atic review and meta-analysis.
@en
Heparin treatment in antiphosp ...... atic review and meta-analysis.
@nl
prefLabel
Heparin treatment in antiphosp ...... atic review and meta-analysis.
@en
Heparin treatment in antiphosp ...... atic review and meta-analysis.
@nl
P2093
P1476
Heparin treatment in antiphosp ...... atic review and meta-analysis.
@en
P2093
Matthaios Pavlou
Michael Voulgarelis
Panayiotis D Ziakas
P304
P356
10.1097/AOG.0B013E3181DEBA40
P407
P577
2010-06-01T00:00:00Z